If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman
If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman
We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.
Please do your part today.
StoryMay 10, 2024
StoryMay 10, 2024
StoryMay 10, 2024
StoryMay 10, 2024
Web ExclusiveMay 06, 2024
Web ExclusiveMay 01, 2024
Web ExclusiveApr 29, 2024
Web ExclusiveApr 23, 2024
The World Health Organization has granted emergency use authorization to India’s COVID-19 vaccine known as Covaxin. The two-dose vaccine is based on an inactivated form of the coronavirus. It’s easily stored and showed 78% efficacy against symptomatic disease in a clinical trial. It’s the eighth COVID-19 vaccine approved by the WHO.
Top